Which drug better protects Kids' pancreas after ERCP? new study has answers
NCT ID NCT05664074
First seen Mar 23, 2026 · Last updated May 23, 2026 · Updated 8 times
Summary
This study looked at 192 children who had an ERCP procedure, which can sometimes cause pancreatitis. Researchers compared two medicines—rectal indomethacin and IV ketorolac—to see which one better prevents this complication. The goal was to find the most effective way to protect young patients from post-ERCP pancreatitis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-ERCP ACUTE PANCREATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
Conditions
Explore the condition pages connected to this study.